Clinical Trials on Glioblastoma With Primitive Neuronal Component in Denmark

Total 2 results

  • Gustave Roussy, Cancer Campus, Grand Paris
    Recruiting
    High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) (HR-NBL2)
    High-Risk Neuroblastoma | Patient With Insufficient Response Chemoimmunotherapy
    France, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia
  • Novartis Pharmaceuticals
    Terminated
    Ceritinib Rare Indications Study in ALK+ Tumors
    Glioblastoma | Anaplastic Large Cell Lymphoma | Inflammatory Myofibroblastic Tumor | Tumors With Aberrations in ALK
    France, Czechia, Italy, Spain, Korea, Republic of, Thailand, Israel, Denmark

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe